# A review of advances in the treatment of diabetic nephropathy by modulating intestinal flora with natural products of traditional Chinese medicine

**Authors:** Tao Wang, Ming Chen, Jiwen Xu, Yuhang Qiao, Xinhui Huang, Xiaoming Yan, Fuli Zhang

PMC · DOI: 10.3389/fphar.2025.1628294 · Frontiers in Pharmacology · 2025-10-01

## TL;DR

This paper reviews how traditional Chinese medicine natural products may help treat diabetic nephropathy by adjusting gut bacteria.

## Contribution

The paper provides a review of recent advances in using TCM natural products to treat DN through gut flora modulation.

## Key findings

- Imbalances in gut microbiota are linked to the progression of diabetic nephropathy.
- Modulating gut flora could be a potential treatment strategy for DN.
- Natural products from traditional Chinese medicine show promise in this area.

## Abstract

Diabetic Nephropathy (DN) is one of the most serious complications of diabetes mellitus (DM). Hemodynamic irregularities, metabolic problems, and hormone production are only a few of the many mediators and routes that contribute to the intricate and varied genesis of DN. DN is the most common cause of end-stage renal disease, which is characterised by persistently low glomerular filtration capacity and hyperglycaemia. Numerous studies have been conducted recently on the function of gut flora in DN. According to current research, the formation and progression of DN have been linked to imbalances in the gut microbiota and abnormal microbial metabolite production. Therefore, intestinal flora modulation may be an entry point for the treatment of DN. As an increasing number of studies are using natural products of traditional Chinese medicine (TCM) as a therapeutic tool, this article reviews the progress of TCM natural products in treating DN by modulating gut microbiota.

## Linked entities

- **Diseases:** Diabetic Nephropathy (MONDO:0005016), diabetes mellitus (MONDO:0005015), end-stage renal disease (MONDO:0004375)

## Full-text entities

- **Diseases:** DM (MESH:D003920), end-stage renal disease (MESH:D007676), DN (MESH:D003928)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12521196/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12521196/full.md

## References

70 references — full list in the complete paper: https://tomesphere.com/paper/PMC12521196/full.md

---
Source: https://tomesphere.com/paper/PMC12521196